Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · Real-Time Price · USD
12.23
+0.21 (1.75%)
Aug 30, 2024, 4:00 PM EDT - Market closed
Astria Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
59
Market Cap
690.08M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Orthofix Medical | 771.65M |
Fulgent Genetics | 290.71M |
Revance Therapeutics | 251.18M |
Paragon 28 | 235.44M |
Adaptive Biotechnologies | 168.77M |
SI-BONE | 150.71M |
Avid Bioservices | 139.91M |
ATXS News
- 1 day ago - Astria Therapeutics to Present at Upcoming Bradykinin Symposium - Business Wire
- 2 days ago - Astria Therapeutics to Participate in Upcoming Morgan Stanley 22nd Annual Global Healthcare Conference - Business Wire
- 19 days ago - Astria Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update - Business Wire
- 19 days ago - Astria Therapeutics Chooses Ypsomed's YpsoMate as the Injection Device for STAR-0215 for the Treatment of Hereditary Angioedema - Business Wire
- 24 days ago - Astria Therapeutics to Participate in Upcoming 2024 Wedbush PacGrow Healthcare Conference - Business Wire
- 4 weeks ago - Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 3 months ago - Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference - Business Wire
- 3 months ago - Astria Therapeutics to Present at Upcoming Eastern Allergy Conference - Business Wire